CROMAZOL Trademark

Trademark Overview

On Tuesday, February 13, 2024, a trademark application was filed for CROMAZOL with the United States Patent and Trademark Office. The USPTO has given the CROMAZOL trademark a serial number of 98404290. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, October 14, 2025. This trademark is owned by Samdolite Pharmaceuticals. The CROMAZOL trademark is filed in the Pharmaceutical Products category with the following description:

Dermatological pharmaceutical products; pharmaceutical preparations for treating skin disorders; pharmaceutical preparations for use in dermatology; medicated topical skin care formulations
cromazol

General Information

Serial Number98404290
Word MarkCROMAZOL
Filing DateTuesday, February 13, 2024
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, October 14, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 19, 2025

Trademark Statements

Goods and ServicesDermatological pharmaceutical products; pharmaceutical preparations for treating skin disorders; pharmaceutical preparations for use in dermatology; medicated topical skin care formulations

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 18, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSamdolite Pharmaceuticals
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSaint Charles, MO 63304
Party NameSamdolite Pharmaceuticals
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSaint Charles, MO 63304

Trademark Events

Event DateEvent Description
Friday, May 31, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, February 16, 2024NEW APPLICATION ENTERED
Monday, March 18, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, May 31, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, May 31, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, September 5, 2024ASSIGNED TO EXAMINER
Monday, September 9, 2024NON-FINAL ACTION E-MAILED
Wednesday, September 25, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 25, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, September 9, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, September 9, 2024NON-FINAL ACTION WRITTEN
Wednesday, September 25, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 15, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, October 15, 2024NON-FINAL ACTION WRITTEN
Tuesday, October 15, 2024NON-FINAL ACTION E-MAILED
Monday, December 9, 2024LETTER OF PROTEST EVIDENCE FORWARDED
Monday, December 9, 2024LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN
Friday, January 3, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 3, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 3, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, February 6, 2025NON-FINAL ACTION E-MAILED
Thursday, February 6, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 6, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 6, 2025NON-FINAL ACTION WRITTEN
Monday, April 28, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 6, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 6, 2025ASSIGNED TO LIE
Thursday, July 10, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 13, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 19, 2025PUBLISHED FOR OPPOSITION
Tuesday, August 19, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 14, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Related Keywords

cromazol pharmaceutical preparations skin topical care formulations medicated dermatology treating dermatological